275 related articles for article (PubMed ID: 28850356)
1. Healthcare resource use and costs of opioid-induced constipation among non-cancer and cancer patients on opioid therapy: A nationwide register-based cohort study in Denmark.
Søndergaard J; Christensen HN; Ibsen R; Jarbøl DE; Kjellberg J
Scand J Pain; 2017 Apr; 15():83-90. PubMed ID: 28850356
[TBL] [Abstract][Full Text] [Related]
2. Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy.
Fine PG; Chen YW; Wittbrodt E; Datto C
Support Care Cancer; 2019 Feb; 27(2):687-696. PubMed ID: 30056531
[TBL] [Abstract][Full Text] [Related]
3. Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study.
Morgan CL; Jenkins-Jones S; Knaggs R; Currie C; Conway P; Poole CD; Berni E
Clin Ther; 2021 Jun; 43(6):968-989. PubMed ID: 33931241
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced constipation, use of laxatives, and health-related quality of life.
Christensen HN; Olsson U; From J; Breivik H
Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
[TBL] [Abstract][Full Text] [Related]
5. The direct and indirect costs of opioid-induced constipation.
Hjalte F; Berggren AC; Bergendahl H; Hjortsberg C
J Pain Symptom Manage; 2010 Nov; 40(5):696-703. PubMed ID: 20727708
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingness-to-pay and cost-benefit analysis.
Iskedjian M; Iyer S; Librach SL; Wang M; Farah B; Berbari J
J Pain Symptom Manage; 2011 Jan; 41(1):104-15. PubMed ID: 20832981
[TBL] [Abstract][Full Text] [Related]
7. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
Gupta S; Patel H; Scopel J; Mody RR
J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
[TBL] [Abstract][Full Text] [Related]
8. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.
Bell T; Annunziata K; Leslie JB
J Opioid Manag; 2009; 5(3):137-44. PubMed ID: 19662923
[TBL] [Abstract][Full Text] [Related]
9. Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department.
Peacock WF; Slatkin N; Gagnon-Sanschagrin P; Maitland J; Guérin A; Joseph G
Adv Ther; 2022 May; 39(5):2178-2191. PubMed ID: 35298784
[TBL] [Abstract][Full Text] [Related]
10. Health care resource use and costs in opioid-treated patients with and without constipation in Brazil.
Takemoto ML; Fernandes RA; Almeida GR; Monteiro RD; Colombini-Neto M; Bertola-Neto A
Value Health; 2011; 14(5 Suppl 1):S78-81. PubMed ID: 21839904
[TBL] [Abstract][Full Text] [Related]
11. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain.
Wan Y; Corman S; Gao X; Liu S; Patel H; Mody R
Am Health Drug Benefits; 2015 Apr; 8(2):93-102. PubMed ID: 26005516
[TBL] [Abstract][Full Text] [Related]
14. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
Goeree R; Goeree J
J Med Econ; 2016; 19(3):277-91. PubMed ID: 26535790
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
[TBL] [Abstract][Full Text] [Related]
17. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
Kwong WJ; Diels J; Kavanagh S
Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
[TBL] [Abstract][Full Text] [Related]
18. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Functional Characteristics of Nursing Facility Residents with Opioid-Induced Constipation.
Allen C; Zarowitz BJ; O'Shea T; Datto C; Olufade T
Consult Pharm; 2017 May; 32(5):285-298. PubMed ID: 28483009
[TBL] [Abstract][Full Text] [Related]
20. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]